Depo Provera, an injected contraceptive used by an estimated 30
million around the world, has been found to more than triple a woman's
risk of two common sexually transmitted diseases, according to a
new study.
Injected in the arm or buttocks once every three months, the popular
contraceptive has been linked to chlamydia and gonorrhea.
Researchers collected data on some 800 women between the ages of
15-45 who were prescribed birth control treatments at two Baltimore-area
hospitals. Two groups of roughly 350 women used either the pill
or a non-hormonal contraceptive while the rest used Depo Provera.
Then, the women were tested for gonorrhea and chlamydia three times
over 12 months.
After the year passed, 45 women had contracted
one of the diseases. The results:
-
Those who used Depo Provera were about 3.5 times more likely
to develop them than women using non-hormonal contraceptives.
-
Pill users were about 50 percent more likely to be infected
than women also using non-hormonal contraceptives.
The moral of the study, scientists said, underscored the need for
women to use condoms along with their hormonal contraceptives and
Depo Provera if they engage in non-monogamous relationships.
USA
Today August 23, 2004
|